BIM
NBSE

BlackRock Investment Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

BlackRock Investment Management’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7K Hold
12
– – ﹤0.01% 3704
2016
Q3 		$13K Hold
12
– – ﹤0.01% 3506
2016
Q2 		$13K Hold
12
– – ﹤0.01% 3527
2016
Q1 		$15K Hold
12
– – ﹤0.01% 3468
2015
Q4 		$29K Buy
12
+1
+9% +$1.53K ﹤0.01% 3353
2015
Q3 		$12K Hold
11
– – ﹤0.01% 3623
2015
Q2 		$11K Sell
11
-145
-93% -$156K ﹤0.01% 3692
2015
Q1 		$158K Buy
156
+3
+2% +$9.9K ﹤0.01% 3250
2014
Q4 		$511K Hold
153
– – ﹤0.01% 2997
2014
Q3 		$445K Buy
153
+3
+2% +$9.92K ﹤0.01% 3034
2014
Q2 		$571K Buy
+150
New +$565K ﹤0.01% 2972

Other funds holding NBSE

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return

BlackRock Investment Management's NBSE Position: Q4 2016 in Review

BlackRock Investment Management held its NeuBase Therapeutics, Inc. Common Stock (NBSE) position steady in Q4 2016 at 12 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #3704.

BlackRock Investment Management first reported a position in NBSE in Q2 2014 and has held it in 11 quarters since. The position peaked at $571K in Q2 2014. 49 funds tracked by Wall St. Rank hold NBSE as of Q4 2016.

  • BlackRock Investment Management held 12 shares of NeuBase Therapeutics, Inc. Common Stock worth $7K as of Q4 2016.
  • BlackRock Investment Management left its NeuBase Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
  • NeuBase Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3704 holding.
  • BlackRock Investment Management first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's NeuBase Therapeutics, Inc. Common Stock position peaked at $571K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.